自闭症治疗贵阳哪里好(贵阳治疗发育迟滞的医院) (今日更新中)

SAN FRANCISCO, Nov. 4 (Xinhua) -- With its popular iPhone series, Apple seized more than half of the profits generated by the top eight mobile phone manufacturers during the third quarter, said a monthly market analysis released on Friday.Apple generated a remarkable 52 percent of handset industry operating profits for the top eight OEMs (original equipment manufacturers) in the third quarter, up five percent over the same period of 2010, said Canaccord Genuity technology analyst Michael Walkley.The number was down from 57 percent in the second quarter, due to a drop in iPhone sales as customers held out for the upcoming iPhone 4S.A proud Apple customer shows off the new iPhone 4S he purchased at an Apple store in Munich, Germany.Apple's major rival in the mobile industry is Samsung. The two companies together represented 81 percent of the handset industry' s operating profits last quarter.Other major mobile phone manufacturers are Nokia, Motorola, Sony Ericsson, HTC, Research In Motion and LG.Calling it "an epic reversal of fortunes," Walkley noted that in 2007, Nokia had 67 percent of operating profits while Apple had just 4 percent. Compared with Apple's 52 percent of industry profits in the third quarter of 2011, Nokia has been relegated to its rival's former position with just 4 percent of operating profits.The analyst said he has conducted "channel checks" that show strong demand not only for the new iPhone 4S but also for the previous models of iPhone 4 and iPhone 3GS. He told technology news website AllthingsD that Apple is believed to be able to gain further value share in the December quarter and capture over 60 percent of industry profits.In a Bloomberg report on Friday, several technology analysts said the two-year-old iPhone 3GS, whose price has been slashed to zero if it is purchased with a contract, will become one of Apple' s big weapons in the coming holiday season against smartphones running Google's Android system.

BEIJING, Nov. 22 (Xinhuanet) -- Underweight patients may have more possibilities of mortality within 30 days of general and vascular surgery compared with mildly obese patients, according to a research published online in Archives of Surgery Tuesday.Researchers at the U.S. National Surgical Quality Improvement Program conducted the research for the years 2005 and 2006, and assessed the contribution of BMI (Body Mass Index) to 189,533 postsurgeries morbidity and mortality by obesity classes.They found that compared with the middle BMI quintile group, patients with BMI value below 23.1, had greater chances for death. For the highest BMI quintile group, higher mortality rate was also observed.However, the researchers also found that obesity may as well be associated with increased mortality for some individual types of surgeries."These individual types of procedures include procedures with which the general surgeon should have definite experience: colorectal resection, colostomy formation, cholecystectomy, hernia repair, mastectomy, and wound debridement," said George J. Stukenborg, PhD, of the University of Virginia inCharlottesvilleand his colleagues.Based on a 30 –day morbidity and mortality risk calculation, the sample patients were categorized into BMI quintile ranges. BMI value of less than 23.1 was considered as lowest, values from 26.3 to 29.6 considered as the middle quintile, and above 35.2 considered as the highest.Factors such as lack of enough data on nonfatal complications and hospital resources, or examining mortality over the 30-day baseline, may cause limitations and inaccuracy to the research and more studies on a wider range of patients in terms of BMI are needed to further confirm the current conclusion, researchers said.

BEIJING, Dec. 4 (Xinhua) -- Acclaimed orthopaedic surgeons and experts attending a major conference in Beijing have agreed to build up a platform for international cooperation aiming at jointly coping with medical and social challenges.At the Sixth International Congress of the Chinese Orthopaedic Association (COA) that concluded on Sunday, presidents of more than 80 national and international orthopaedic societies signed a declaration which seeks a model for both developing and developed countries to help reduce medical costs in the aftermath of the global financial crisis.With an aging global population, rapidly rising medical costs have become a heavy financial burden for governments worldwide. Medical insurance cost control has become a hot topic around the world.Bone and joint diseases, infections due to traffic accident traumas and other diseases causing high disability rates have affected millions of people worldwide."One of the objectives of the COA international conference is to provide a platform for medical experts around the world to discuss not only clinical techniques but also medical and social problems," said Professor Wang Yan, chairman of the COA.To fully leverage existing professional knowledge and resources, presidents of orthopaedic organizations attending the conference adopted and released the Beijing Declaration which calls for a platform to enhance global and national collaboration and partnerships among the professions, industries and related patient organizations and disciplines.The declaration also stresses maximizing Internet-based learning and encouraging international exchanges."Worldwide, I have one lament, that we've spent so much money on medical research, but very little on orthopaedics. Most governments are more anxious to fund cancer or infectious diseases," said Professor Michael Huggness, president of the North American Spine Society."We think we're a bit handicapped by not having the money to pursue the research. As we get more sophisticated in our treatment, the price does go up. My expectation is that in another five to 10 years, we'll begin to apply some molecular techniques to assist us in healing. Maybe the price will come down when our knowledge base increases. But I think we'll just have to wait for a bit more research and a bit more basic science.""We definitely will... look into this issue of how we can have a suitably assigned budget from the government for orthopaedic care," said Professor K.M. Chan, from the Prince of Wales Hospital in Hong Kong."At the same time, we use evidence-based medicine to contain the medical cost in orthopaedics with very stringent monitors from the professions. That involves good-practice models, quality insurance and patient safety. With all these, we expect that the profession will be heading forward to join hands with the government to contain the cost."More than 15,000 surgeons, researchers and business representatives from China and abroad are attending the four-day annual conference to share the latest theories and techniques for curing musculoskeletal diseases as well as related social topics.Founded in 1980, the COA now has more than 30,000 registered members and is the largest sub-society of doctors under the Chinese Medical Association. The conference is the largest medical academic event in China.

BEIJING, Jan. 4 (Xinhua) -- The Chinese currency Renminbi, or the yuan, rose 8 basis points to a record high of 6.3001 against the U.S. dollar on Wednesday, according to the China Foreign Exchange Trading System.In China's foreign exchange spot market, the yuan is allowed to rise or fall by 0.5 percent from the central parity rate each trading day.The central parity rate of the yuan against the U.S. dollar is based on a weighted average of prices before the opening of the market each business day.

BEIJING, Oct. 7 (Xinhua) -- Chinese scientists are developing new methods like spraying or dropping hepatitis vaccines into people's noses to replace traditional injections, according to a leading expert on immunology.Such researches were sponsored by a key national science project, according to Wen Yumei, an academician of the Chinese Academy of Engineering, also the chairwoman of the 14th International Symposium on Viral Hepatitis and Liver Disease, which is scheduled to be held in Shanghai next July.At a press conference held here Friday for the symposium, experts believed that broad-coverage inoculations is an effective way in facilitating the country's goal in controlling Hepatitis B.China's Ministry of Health has also credited its national immunization program for having protected about 80 million people from being infected with the Hepatitis B virus (HBV) in the 19 years after 1992.Recent report showed that about 93 million Chinese are HBV carriers, accounting for more than a quarter of the world's total.

来源：资阳报